CD34 and leukemia: Therefore, it was concluded that the reason for the increase in the P-gp positivity rate observed in the RR patient group was due not to induction by chemotherapeutics, but to the elimination of leukemia cells that were sensitive to treatment, which allowed the CD34+/P-gp+ subgroup of cells to preferentially proliferate.